MedPath
TGA Approval

DESCOVY 200 mg/25 mg ( 200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle (246092)

246092

DESCOVY 200 mg/25 mg ( 200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle

Gilead Sciences Pty Ltd

July 1, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-02121-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02118-1

Active Ingredients

emtricitabine

tenofovir alafenamide fumarate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DESCOVY 200 mg/25 mg ( 200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle (246092) - TGA 批准文号 | MedPath